Increasing generic drug use in medicare part D: The role of government

被引：23
|
作者：
Kohl, Herb
Shrank, William H. [1 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] US Senate, US Senate Special Comm Aging, Washington, DC 20510 USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2007年 / 55卷 / 07期
关键词：
D O I：
10.1111/j.1532-5415.2007.01286.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
[No abstract available]
引用
收藏
页码：1106 / 1109
页数：4
相关论文
共 50 条
  • [41] The role of government policy in increasing drug use: Java']Java, 1875-1914
    Chandra, S
    JOURNAL OF ECONOMIC HISTORY, 2002, 62 (04): : 1116 - 1121
  • [42] The impact of Medicare part D prescription drug benefit program on generic drug prescription A study in long-term care facilities
    Jung, Changmi
    Padman, Rema
    Anwar, Shamena
    MEDICINE, 2019, 98 (32)
  • [43] Medicare Part D and Changes in Prescription Drug Use and Cost Burden National Estimates for the Medicare Population, 2000 to 2007
    Briesacher, Becky A.
    Zhao, Yanfang
    Madden, Jeanne M.
    Zhang, Fang
    Adams, Alyce S.
    Tjia, Jennifer
    Ross-Degnan, Dennis
    Gurwitz, Jerry H.
    Soumerai, Stephen B.
    MEDICAL CARE, 2011, 49 (09) : 834 - 841
  • [44] Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
    Karel H. van der Pol
    Mohamad Aljofan
    Olivier Blin
    Jan H. Cornel
    Gerard A. Rongen
    Aurélie-Gaëlle Woestelandt
    Michael Spedding
    Applied Health Economics and Health Policy, 2023, 21 : 831 - 840
  • [45] Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
    van der Pol, Karel H.
    Aljofan, Mohamad
    Blin, Olivier
    Cornel, Jan H.
    Rongen, Gerard A.
    Woestelandt, Aurelie-Gaelle
    Spedding, Michael
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (06) : 831 - 840
  • [46] Nonlinear Pricing in Drug Benefits and Medication Use: The Case of Statin Compliance in Medicare Part D
    Jung, Kyoungrae
    Feldman, Roger
    McBean, A. Marshall
    HEALTH SERVICES RESEARCH, 2014, 49 (03) : 910 - 928
  • [47] Prescription drug use under Medicare Part D: A linear model of nonlinear budget sets
    Abaluck, Jason
    Gruber, Jonathan
    Swanson, Ashley
    JOURNAL OF PUBLIC ECONOMICS, 2018, 164 : 106 - 138
  • [48] Has Medicare Part D Reduced Racial/Ethnic Disparities in Prescription Drug Use and Spending?
    Mahmoudi, Elham
    Jensen, Gail A.
    HEALTH SERVICES RESEARCH, 2014, 49 (02) : 502 - 525
  • [49] Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label
    Egilman, Alexander C.
    Kesselheim, Aaron S.
    Sarpatwari, Ameet
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 833 - 835
  • [50] Opioid use in older adults and Medicare Part D
    Sabety, Adrienne H.
    Sherry, Tisamarie B.
    Maestas, Nicole
    HEALTH SERVICES RESEARCH, 2021, 56 (02) : 289 - 298
12345